Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

Rosen & Barkin's 5-Minute Emergency Medicine Consult (770 page)

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
4.79Mb size Format: txt, pdf, ePub
ads
ED TREATMENT/PROCEDURES
  • Verbal de-escalation:
    • Attempt to clarify and validate patient’s immediate concerns
    • Calmly explain potential need for a restraint if de-escalation is not successful
    • Offer patient choices when possible
  • Seclusion:
    • If an appropriate room is available, this may obviate the need for restraint
  • Physical restraint:
    • Follow your institutional protocol
    • Must document appropriate reason for restraint, attempts to verbally de-escalate, and plans for appropriate monitoring and reassessments
    • Whenever possible, treating physician should not be part of restraint team
    • Use leather restraints for combative patients; soft restraints for patients who are unlikely to be combative or try to elope
    • Supine position if patient needs to be examined; side position if aspiration risk is significant
    • If restraint in prone position is needed, ensure adequate airway is maintained
  • Chemical restraint:
    • Offer voluntary PO or IM sedative medication prior to initiating involuntary restraint
    • Avoid PO medications for involuntary restraint due to bite risk
    • Choice of medication should depend on underlying cause; either a benzodiazepine or a neuroleptic or both may be appropriate:
      • If agitation results from delirium or other medical condition, 1st attempt to treat the underlying cause
      • Consider benzodiazepines for hyperadrenergic (including cocaine) state or if there is a contraindication to neuroleptics
      • Consider neuroleptics for most primary medical or psychiatric causes, sedative intoxication, or primary behavioral cause
      • Often used in combination
    • Contraindications to neuroleptics:
      • Knowledge of or suspicion for Parkinson disease, dementia with Lewy bodies or frontotemporal dementia
      • Neuroleptic malignant syndrome, dystonic reaction, or catatonia
      • Prolonged QT
      • Anticholinergic overdose
    • Potential adverse effects:
      • Dystonia: Treat with IM benztropine 1 mg or IM diphenhydramine 50 mg
      • QTc prolongation and/or torsades de pointes (rare)
      • Neuroleptic malignant syndrome (rare): Stop all antipsychotics; begin intensive monitoring and supportive care
MEDICATION
ALERT
  • Patients who are elderly, have medical or neurologic illness, or have cognitive impairment are more vulnerable to adverse effects and may respond to lower doses (e.g., haloperidol 0.5 mg)
  • If 1st dose of IM haloperidol is ineffective, may be repeated after 30–60 min.
  • First line:
    • Haloperidol: 5–10 mg IV, IM, or PO
    • Lorazepam: 1–2 mg IV, IM, or PO
  • Second line:
    • Droperidol: 2.5–5 mg IV or IM; watch QTc
    • Olanzapine: 5–10 mg IM or PO; if IM, do not give with IM/IV benzodiazepines due to risk of respiratory depression
    • Risperidone: 0.5–1 mg PO
    • Ziprasidone: 10 mg IM every 2 hr, not to exceed 40 mg IM per day
FOLLOW-UP
DISPOSITION
Admission Criteria
  • Medical admission for medical conditions not temporary or reversible in the ED
  • Medical admission if further medical workup needed for which ED setting is not optimal
  • Psychiatric admission if patient has a treatable psychiatric illness appropriate for inpatient level of care
  • Involuntary admission for safety may be necessary according to criteria defined by individual state laws
Discharge Criteria
  • Underlying medical or psychiatric causes have been stabilized
  • Appropriate follow-up is in place
  • Access to weapons has been assessed
  • If intoxication played a role in presentation, sober re-evaluation should occur prior to discharge
  • Discharge to police custody may be appropriate if no psychiatric or medical issues remain
  • If patient elopes, must consider imminent danger to self or others; notify police if risk is high or if safety evaluation not complete
  • Duty to warn or protect 3rd parties from risk of harm: “Tarasoff” laws vary among states, so know yours
ADDITIONAL TREATMENT
Issues for Referral
  • Psychiatric consultation in the ED can be helpful, especially if primary mental illness suspected
  • Other consultation may be indicated based on the underlying etiology
FOLLOW-UP RECOMMENDATIONS
  • Patients with psychiatric illness should follow-up with community mental health provider
  • Patients who are using substances should be offered counseling and/or detox
PEARLS AND PITFALLS
  • Do not assume that patients with violent behavior have only psychiatric problems
  • Patients who have been restrained require appropriate monitoring, including regular nursing checks and VS, and labs/ECG if chemical restraints are used
  • “Distracting staff” is annoying and may interfere with the care of other patients, but this is not an indication for restraints
  • Document need for restraints and renewal of restraints per your hospital’s protocol
ADDITIONAL READING
  • Coburn VA, Mycyk MB. Physical and chemical restraints.
    Emerg Med Clin North Am
    . 2009;27:655–667.
  • Lukens TW, Wolf SJ, Edlow JA, et al. Clinical policy: Critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department.
    Ann Emerg Med
    . 2006;47(1):79–99.
  • Richmond JS, Berlin JS, Fishkind AB, et al. Verbal De-escalation of the Agitated Patient: Consensus Statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup.
    West J Emerg Med
    . 2012;13(1):17–25.
  • Rossi J, Swan MC, Isaacs ED. The violent or agitated patient.
    Emerg Med Clin North Am.
    2010;28:235–256.
  • Tishler CL, Reiss NS, Dundas J. The assessment and management of the violent patient in critical hospital settings.
    Gen Hosp Psychiatry
    . 2013;35:181–185.
  • Wilson MP, Pepper D, Currier GW, et al. The psychopharmacology of agitation: Consensus statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup.
    West J Emerg Med
    . 2012;13(1):26–34.
  • Zun LS. Pitfalls in the care of the psychiatric patient in the emergency department.
    J Emerg Med.
    2012;43(5):829–835.
See Also (Topic, Algorithm, Electronic Media Element)
  • Psychosis, Acute
  • Delirium
CODES
ICD9
  • 292.89 Other specified drug-induced mental disorders
  • 312.9 Unspecified disturbance of conduct
  • 312.30 Impulse control disorder, unspecified
ICD10
  • F19.929 Oth psychoactive substance use, unsp with intoxication, unsp
  • F63.9 Impulse disorder, unspecified
  • R45.6 Violent behavior
VISUAL LOSS
Jason Hoppe
BASICS
DESCRIPTION
  • Decrease in visual function (i.e., visual acuity, visual fields, blurry vision)
  • Visual loss has many etiologies and can be caused by multiple body systems
ETIOLOGY
  • Ophthalmologic:
    • Eyelid or tear film abnormality
    • Anterior segment (cornea, anterior chamber, iris, lens)
    • Posterior segment (vitreous, retina, optic nerve)
    • Posterior to the eye (optic nerve, chiasm, radiations)
  • Traumatic:
    • Corneal abrasion
    • Hyphema
    • Lens dislocation
    • Ruptured globe
    • Commotio retinae
    • Retinal detachment
    • Retinal/vitreous hemorrhage
    • Retrobulbar hemorrhage
    • Intraocular foreign body
  • Neurologic:
    • Cerebral (cerebrovascular accident [CVA]) or intracranial pathology (mass lesion)
    • Multiple sclerosis
    • Optic neuritis
    • Migraine
  • Cardiovascular system:
    • Embolic
    • Thrombotic
    • Ischemic
    • Hypertensive events
  • Immunologic system:
    • Uveitis
    • Giant cell arteritis
  • Infection:
    • Orbital cellulitis/abscess
    • Cavernous sinus thrombosis
    • HIV optic neuropathy or cytomegalovirus (CMV) retinitis
  • Endocrine:
    • Diabetic retinopathy
    • Thyroid disease may cause diplopia (muscle hypertrophy) or corneal erosions
  • Toxic:
    • Methanol (acute severe loss, subacute optic atrophy)
    • Licorice (transient loss, self-limited)
    • Digitalis (flashing lights, color changes)
    • Amiodarone (rare cause of optic neuropathy)
BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
4.79Mb size Format: txt, pdf, ePub
ads

Other books

Joyride by Anna Banks
Wade by Jennifer Blake
Ink (The Haven Series) by Torrie McLean
Tales of the Hidden World by Simon R. Green
Unti Lucy Black Novel #3 by Brian McGilloway
The Dark Road by Ma Jian
1911021494 by Michael Hambling